Analysis

Ginkgo Bioworks Holdings, Inc. (DNA) Stock Analysis

Ginkgo Bioworks Holdings, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to DNA.

websiteDNA/analysis/DNA

Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks Holdings, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to DNA.

Stock profile

Ticker

DNA

Asset type

Stock

Market cap

$599.0M

Sector

Health Services

Industry

Medical/Nursing Services

Currency

USD

Ticker listings

Ginkgo Bioworks Holdings, Inc. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

  • DNA primary listing
  • 9L40
  • A40KL9

Latest Ginkgo Bioworks Holdings, Inc. news

Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Launch ADME-One™: a High-Throughput ADME Platform That Brings Pharmacokinetic P...

Ginkgo Bioworks (NYSE: DNA) today announced that its Datapoints offering is launching ADME-One™, a fully integrated ADME platform for drug discovery teams co-developed with Tang...

Ginkgo Bioworks Reports First Quarter 2026 Financial Results, Completes Divestiture of Biosecurity and Continues to Scale Autonomous Lab

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo") today announced its results for the first quarter of 2026 that ended March 31, 2026. The update, including a webcast slide p...

Ginkgo Bioworks Announces Date of First Quarter 2026 Results Presentation

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo") today announced that it plans to host a presentation and Q&A session reviewing business performance for the first quarter en...

Ginkgo Bioworks Launches Ginkgo Cloud Lab, Powered by Autonomous Lab Infrastructure

Ginkgo Bioworks (NYSE: DNA) today announced the official launch of Ginkgo Cloud Lab. This new interface allows researchers to transition their benchwork to Ginkgo's autonomous l...

Ginkgo Bioworks Reports Fourth Quarter and Full Year 2025 Financial Results, Announces Focus on Autonomous Labs Offerings and Divestiture...

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo") today announced its results for the fourth quarter and full year ended December 31, 2025. The update, including a webcast sl...

Research sections

Valuation

Review valuation context for Ginkgo Bioworks Holdings, Inc..

Future growth

Review future growth context for Ginkgo Bioworks Holdings, Inc..

Past performance

Review past performance context for Ginkgo Bioworks Holdings, Inc..

Financial health

Review financial health context for Ginkgo Bioworks Holdings, Inc..

Dividend

Review dividend context for Ginkgo Bioworks Holdings, Inc..

Management

Review management context for Ginkgo Bioworks Holdings, Inc..

Ownership

Review ownership context for Ginkgo Bioworks Holdings, Inc..

Other information

Review other information context for Ginkgo Bioworks Holdings, Inc..

Community

Review community context for Ginkgo Bioworks Holdings, Inc..